To develop and validate a non-invasive magnetic resonance imaging (MRI)-based deep learning and radiomics approach for the preoperative differentiation of p53 abnormal (P53abn) endometrial cancer, facilitating refined risk stratification for personalized treatment planning.

Read the full article on ejradiology.com